Skip to content

Personalis, Inc. PSNL Return on equity

Return on equity at other companies

Quest Diagnostics logo
Quest DiagnosticsDGX
14.3%+0.9pp
NeoGenomics logo
NeoGenomicsNEO
-11.6%+6.2pp
Illumina logo
IlluminaILMN
33.8%+23.9pp
Veracyte logo
VeracyteVCYT
6.9%+4.1pp
Guardant Health logo
Guardant HealthGH
-438.1%-1,655pp
Natera, Inc. logo
Natera, Inc.NTRA
-29%+4.1pp

Other financials

Income statement

See full
Revenue$15.5M-24.9%
Gross profit$281.0K-96.1%
Operating income-$32.2M-81.7%
Net income-$30.0M-90.7%
EPS (diluted)-$0.29-61.1%

Balance sheet

See full
Cash & equivalents$73.6M+3.7%
Total debt$39.0M-6.2%
Total equity$254.8M+22.9%
Total assets$325.4M+19.1%

Cash flow

See full
Operating cash flow-$22.5M-25.1%
CapEx$3.2M+27.1%
Free cash flow-$25.7M-25.4%

Valuation

See full
Market cap$1.19B+110%
Enterprise value$1.16B+115%
P/S18.4×+11.8×

Profitability

See full
Gross margin13.7%-19.6pp
Operating margin-158.9%-5,457pp
Net margin-148.1%+154pp
FCF margin-131.2%-453pp

Returns & leverage

See full
Debt / equity0.2×0.0×
Current ratio6.6×-0.3×

Where this comes from

Calculated from Personalis, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Personalis, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Personalis, Inc.'s return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Personalis, Inc.'s return on equity?
Personalis, Inc. (PSNL) reported return on equity of -41.4% in Q1 2026.
How has Personalis, Inc.'s return on equity changed year-over-year?
Personalis, Inc.'s return on equity increased by 19.3% year-over-year, from -51.3% to -41.4%.
What is the long-term trend for Personalis, Inc.'s return on equity?
Over 5 years (2020 to 2025), Personalis, Inc.'s return on equity has grown at a 5.1% compound annual growth rate (CAGR), from -27.4% to -35%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.